Table 2.
Heart rate (HR), high-frequency heart-rate variability (HF-HRV) and respiratory frequency (RF) summary descriptive statistics.
| Descriptive | |||||
|---|---|---|---|---|---|
| METRIC | Group | Treatment | Mean | Standard deviation | N (valid) |
| HR | CHR-P | OT | 61.79 | 9.16 | 28 |
| CHR-P | PL | 61.32 | 8.15 | 28 | |
| HC | OT | 58.81 | 8.19 | 16 | |
| HC | PL | 59.71 | 6.02 | 14 | |
| HF-HRV | CHR-P | OT | 7.51 | 1.08 | 28 |
| CHR-P | PL | 7.16 | 1.00 | 28 | |
| HC | OT | 7.19 | 0.96 | 16 | |
| HC | PL | 7.37 | 0.80 | 14 | |
| RF | CHR-P | OT | 16.48 | 2.28 | 27 |
| CHR-P | PL | 16.32 | 2.83 | 26 | |
| HC | OT | 15.36 | 1.85 | 16 | |
| HC | PL | 15.44 | 2.35 | 14 | |
CHR-P clinical high-risk for psychosis, HC healthy men, OT oxytocin, PL placebo.